Jeffrey Mezger - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Read More

General business news

KB Home Q3 2025 results: Earnings fall but buybacks and liquidity remain in focus

KB Home Q3 2025 earnings show weaker profit but strong buybacks and liquidity. Discover what this means for investors and the housing market outlook.

byPallavi Madhiraju

September 25, 2025

web analytics